NCT06043310View on ClinicalTrials.gov

Estrogen and Microvascular Function

Active, not recruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2031

Conditions
EstrogenCardiovascular DiseasesMicrovasculatureOral Contraceptive Use
Interventions
DRUG

Nω-nitro-L-arginine methyl ester (L-NAME)

L-NAME will be infused locally through microdialysis catheters.

DRUG

Acetylcholine

ACh will be infused locally through microdialysis catheters.

DRUG

Sodium Nitroprusside

SNP will be infused locally through microdialysis catheters.

Trial Locations (1)

53226

Froedtert Hospital, Wauwatosa

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER